Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

High correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats.

Bäck S, Raki M, Tuominen RK, Raasmaja A, Bergström K, Männistö PT.

EJNMMI Res. 2013 Jun 10;3(1):46. doi: 10.1186/2191-219X-3-46.

PMID:
23758882
[PubMed]
Free PMC Article
2.

Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.

Scherfler C, Donnemiller E, Schocke M, Dierkes K, Decristoforo C, Oberladstätter M, Kolbitsch C, Zschiegner F, Riccabona G, Poewe W, Wenning G.

Neuroimage. 2002 Sep;17(1):128-41.

PMID:
12482072
[PubMed - indexed for MEDLINE]
3.

Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.

Jeon BS, Jeong JM, Park SS, Kim JM, Chang YS, Song HC, Kim KM, Yoon KY, Lee MC, Lee SB.

Ann Neurol. 1998 Jun;43(6):792-800.

PMID:
9629849
[PubMed - indexed for MEDLINE]
4.

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.

J Nucl Med. 1998 Sep;39(9):1500-8.

PMID:
9744331
[PubMed - indexed for MEDLINE]
Free Article
5.

N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2004 Dec 16 [updated 2011 Feb 01].

6.

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.

J Nucl Med. 1998 Jul;39(7):1143-8.

PMID:
9669384
[PubMed - indexed for MEDLINE]
Free Article
7.

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, Wolters EC, van Royen EA.

J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):133-40.

PMID:
9048712
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.

Andringa G, Drukarch B, Bol JG, de Bruin K, Sorman K, Habraken JB, Booij J.

Neuroimage. 2005 Jul 15;26(4):1150-8.

PMID:
15908232
[PubMed - indexed for MEDLINE]
9.

In vivo evaluation of the dopaminergic neurotransmission system using [123 I]FP-CIT SPECT in 6-OHDA lesioned rats.

Niñerola-Baizán A, Rojas S, Bonastre M, Tudela R, Lomeña F, Pavía J, Marin C, Ros D.

Contrast Media Mol Imaging. 2014 May 28. doi: 10.1002/cmmi.1608. [Epub ahead of print]

PMID:
24888455
[PubMed - as supplied by publisher]
10.

123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.

Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y.

J Nucl Med. 2004 Oct;45(10):1688-93.

PMID:
15471834
[PubMed - indexed for MEDLINE]
Free Article
11.

Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT.

Pitkonen M, Hippeläinen E, Raki M, Andressoo JO, Urtti A, Männistö PT, Savolainen S, Saarma M, Bergström K.

EJNMMI Res. 2012 Sep 29;2(1):55. doi: 10.1186/2191-219X-2-55.

PMID:
23021250
[PubMed]
Free PMC Article
12.

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

Innis RB, Marek KL, Sheff K, Zoghbi S, Castronuovo J, Feigin A, Seibyl JP.

Mov Disord. 1999 May;14(3):436-42.

PMID:
10348466
[PubMed - indexed for MEDLINE]
13.

Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.

Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK.

Neuroimage. 2005 Feb 1;24(3):822-31. Epub 2004 Nov 24.

PMID:
15652317
[PubMed - indexed for MEDLINE]
14.

Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.

Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W.

Brain. 2005 Jul;128(Pt 7):1605-12. Epub 2005 Apr 7.

PMID:
15817519
[PubMed - indexed for MEDLINE]
Free Article
15.

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.

Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seibyl J.

Neurology. 2001 Dec 11;57(11):2089-94.

PMID:
11739831
[PubMed - indexed for MEDLINE]
16.

Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.

Jeon B, Kim JM, Jeong JM, Kim KM, Chang YS, Lee DS, Lee MC.

J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):60-4.

PMID:
9667562
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry.

Depboylu C, Maurer L, Matusch A, Hermanns G, Windolph A, Béhé M, Oertel WH, Höglinger GU.

Neuroimage. 2013 Oct 1;79:191-200. doi: 10.1016/j.neuroimage.2013.04.076. Epub 2013 Apr 28.

PMID:
23631981
[PubMed - indexed for MEDLINE]
18.

Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.

Ichise M, Kim YJ, Erami SS, Ballinger JR, Vines D, Tanaka F, Lang AE.

J Nucl Med. 1999 Apr;40(4):530-8.

PMID:
10210210
[PubMed - indexed for MEDLINE]
Free Article
19.

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL, et al.

Synapse. 1993 Apr;13(4):295-309.

PMID:
7683143
[PubMed - indexed for MEDLINE]
20.

SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.

Sakakibara R, Shinotoh H, Uchiyama T, Yoshiyama M, Hattori T, Yamanishi T.

J Neurol Sci. 2001 Jun 15;187(1-2):55-9.

PMID:
11440745
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk